Brian K Halak's Net Worth

$92.4 Thousand

Estimate Recalculated Nov 4, 2024 02:33AM EST

Who is Brian K Halak

Brian K Halak does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Volcano Corp, Bionano Genomics, Inc., Orexigen Therapeutics, Inc., ZOGENIX, INC., TANDEM DIABETES CARE INC, MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, VERACYTE, INC., Atara Biotherapeutics, Inc., Aldeyra Therapeutics, Inc., Vanda Pharmaceuticals Inc., Syndax Pharmaceuticals Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., Alliqua BioMedical, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, aTYR PHARMA INC, ALIMERA SCIENCES INC, OTONOMY, INC., Neothetics, Inc., NOVACEA INC, Durata Therapeutics, Inc., Ocera Therapeutics, Inc., Achaogen Inc, Regado Biosciences Inc, ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, CADENCE PHARMACEUTICALS INC, and Northstar Neuroscience, Inc..

SEC CIK

Brian K Halak's CIK is 0001354718

Past Insider Trading and Trends

2014 was Brian K Halak's most active year for acquiring shares with 4 total transactions. Brian K Halak's most active month to acquire stocks was the month of May. 2008 was Brian K Halak's most active year for disposing of shares, totalling 1 transactions. Brian K Halak's most active month to dispose stocks was the month of February. 2019 saw Brian K Halak paying a total of $0.00 for 50,000 shares, this is the most they've acquired in one year. In 2008 Brian K Halak cashed out on 4,297 shares for a total of $53,325.77, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc

Investor
Updated Nov 06, 2018
Form 4
-11.39%
-335.00K
$13.33
-$4.46M
Nov 06, 2018
2.61M
Sale
Nov 02 - Nov 06
Form 4/A
-16.12%
-565.00K
$13.66
-$7.72M
Nov 05, 2018
2.94M
Sale
Oct 30 - Nov 01
Form 4
-8.53%
-564.30K
$13.61
-$7.71M
Nov 01, 2018
6.05M
Sale
Oct 30 - Nov 01
Form 4
25.00K
Jun 25, 2018
25.00K
Grant
Jun 21
Form 4
-0.29%
-10.27K
$10.73
-$36.95
Jun 11, 2018
3.51M
Options
Jun 07
Form 4
92.42%
12.36K
$3.19
Dec 20, 2017
25.73K
Options
Dec 18
Form 4
92.47%
1.67M
$3.19
Dec 20, 2017
3.47M
Options
Dec 18
Form 4
25.00K
Jul 20, 2017
25.00K
Grant
Jul 18
Form 4
368.00
$100.00
$36.80K
Apr 12, 2017
368.00
Purchase
Apr 11
Form 4
49.63K
$100.00
$4.96M
Apr 12, 2017
49.63K
Purchase
Apr 11
Form 4
15.00K
Jun 16, 2016
15.00K
Grant
Jun 14
Form 4
15.00K
Jun 29, 2015
15.00K
Grant
Jun 25
Form 4
15.00K
Jun 20, 2014
15.00K
Grant
Jun 18
Form 4/A
25.00K
Apr 30, 2014
25.00K
Grant
Apr 16
Form 4
25.00K
Apr 18, 2014
25.00K
Grant
Apr 16
Form 4
Feb 04, 2014
1.79M
Options
Feb 04
Form 3
Jan 29, 2014
Showing 17 results

Bionano Genomics, Inc.

Investor
Updated Aug 27, 2018
Form 4
-96.38%
-183.36K
$4.59
Aug 27, 2018
6.89K
Options
Aug 23
Form 4
-90.87%
-24.68M
$5.36
$1.64M
Aug 27, 2018
2.48M
Buy-Options
Aug 23
Form 3
Aug 21, 2018
Form 3
Aug 21, 2018
140.00
Form 3
Aug 21, 2018
Showing 5 results

MARINUS PHARMACEUTICALS INC

Investor
Updated Jul 31, 2014
Form 3
Jul 31, 2014
42.55K
Showing 1 results

GLAUKOS Corp

Investor
Updated Jul 01, 2015
Form 4
Jul 01, 2015
876.08K
Options
Jun 30
Form 4
Jul 01, 2015
6.50K
Options
Jun 30
Form 3
Jun 24, 2015
Form 3
Jun 24, 2015
Form 3
Jun 24, 2015
63.20K
Showing 5 results

Atara Biotherapeutics, Inc.

Investor
Updated Oct 21, 2014
Form 4
13.10%
1.84K
$11.00
Oct 21, 2014
15.89K
Purchase
Oct 21
Form 4
13.11%
248.16K
$11.00
Oct 21, 2014
2.14M
Purchase
Oct 21
Form 3
Oct 15, 2014
Form 3
Oct 15, 2014
Showing 4 results

Aldeyra Therapeutics, Inc.

Investor
Updated May 01, 2014
Form 3
May 01, 2014
10.36K
Showing 1 results

Syndax Pharmaceuticals Inc

Investor
Updated Mar 08, 2016
Form 4
Mar 08, 2016
5.64K
Options
Mar 08
Form 4
Mar 08, 2016
761.06K
Options
Mar 08
Form 3
Mar 02, 2016
Form 3
Mar 02, 2016
Form 3
Mar 02, 2016
13.56K
Showing 5 results

Alliqua BioMedical, Inc.

Investor
Updated May 13, 2019
Form 3
May 13, 2019
22.53K
Form 3
May 13, 2019
3.04M
Showing 2 results

OBALON THERAPEUTICS INC

Investor
Updated Aug 08, 2019
Form 4
77.65%
437.50K
$4.00
$1.75M
Aug 08, 2019
1.00M
Purchase
Aug 06
Form 4
41.35%
1.65M
$1.82
$3.00M
Aug 27, 2018
5.63M
Purchase
Aug 23
Form 4
7.91%
3.63K
Oct 14, 2016
49.57K
Options
Oct 12
Form 4
5.65%
213.04K
Oct 14, 2016
3.99M
Options
Oct 12
Form 3
Oct 05, 2016
Form 3
Oct 05, 2016
Showing 6 results

aTYR PHARMA INC

Investor
Updated May 12, 2015
Form 4
-87.57%
-94.46K
May 12, 2015
13.41K
Options
May 12
Form 4
-87.56%
-12.73M
May 12, 2015
1.81M
Options
May 12
Form 3
May 06, 2015
Form 3
May 06, 2015
Form 3
May 06, 2015
12.57K
Showing 5 results

OTONOMY, INC.

Investor
Updated Aug 18, 2014
Form 4
-2.31%
-277.00
$12.40
-$19.42
Aug 18, 2014
11.72K
Options
Aug 18
Form 4
-2.30%
-37.22K
$12.40
-$17.55
Aug 18, 2014
1.58M
Options
Aug 18
Form 3
Aug 12, 2014
Form 3
Aug 12, 2014
Showing 4 results

Neothetics, Inc.

Investor
Updated Dec 10, 2014
Form 4/A
-81.56%
-212.39K
$11.27
-$37.56K
Dec 10, 2014
48.03K
Options
Nov 25
Form 4/A
-81.29%
-13.43M
$11.86
-$2.20M
Dec 10, 2014
3.09M
Buy-Options
Nov 25
Form 3/A
Nov 26, 2014
Form 3/A
Nov 26, 2014
Form 4
-81.56%
-212.39K
$11.27
-$37.56K
Nov 26, 2014
48.02K
Options
Nov 25
Form 4
-81.29%
-13.43M
$11.86
-$2.20M
Nov 26, 2014
3.09M
Buy-Options
Nov 25
Form 3
Nov 19, 2014
Form 3
Nov 19, 2014
3.93K
Form 3
Nov 19, 2014
Showing 9 results

Durata Therapeutics, Inc.

Investor
Updated Nov 18, 2014
Form 4
-100.00%
-3.01M
Nov 18, 2014
Disposition
Nov 17
Form 4
-100.00%
-22.31K
Nov 18, 2014
Disposition
Nov 17
Form 4
-100.00%
-6.25K
Nov 18, 2014
Disposition
Nov 17
Form 4
34.95%
784.31K
$9.00
Jul 24, 2012
3.03M
Purchase
Jul 24
Form 3
Jul 18, 2012
6.25K
Showing 5 results

Regado Biosciences Inc

Investor
Updated May 06, 2015
Form 3
May 06, 2015
47.61K
Form 3
May 06, 2015
3.28M
Form 3
Aug 21, 2013
17.17K
Showing 3 results

Esperion Therapeutics, Inc.

Investor
Updated Mar 24, 2015
Form 4
-13.63%
-350.00K
Mar 24, 2015
2.22M
Disposition
Mar 20
Form 4
24.19%
500.00K
$20.00
$10.00M
Oct 21, 2014
2.57M
Purchase
Oct 21
Form 4
-6.08%
-140.72K
$14.00
Jul 02, 2013
2.17M
Buy-Options
Jul 01
Form 3
Jun 25, 2013
21.47K
Showing 4 results

Clovis Oncology, Inc.

Investor
Updated Jun 05, 2013
Form 4
-5.94%
-2.78K
$64.58
-$179.47K
Jun 05, 2013
44.03K
Sale
Jun 04
Form 4
-5.81%
-159.19K
$64.58
-$10.28M
Jun 05, 2013
2.58M
Sale
Jun 04
Form 4
-8.36%
-250.00K
$24.59
-$6.15M
Mar 06, 2013
2.74M
Sale
Mar 04 - Mar 06
Form 4
-8.23%
-4.20K
$24.59
-$103.30K
Mar 06, 2013
46.81K
Sale
Mar 04 - Mar 06
Form 4
-43.70%
-2.36M
$13.00
Nov 21, 2011
3.04M
Buy-Options
Nov 21
Form 3
Nov 15, 2011
32.76K
Showing 6 results

Evoke Pharma Inc

Investor
Updated May 27, 2016
Form 4
-36.28%
-5.88K
$4.70
-$27.64K
May 27, 2016
10.33K
Sale
May 26
Form 4
-36.21%
-344.12K
$4.70
-$1.62M
May 27, 2016
606.28K
Sale
May 26
Form 4
-0.50%
-82.00
$5.07
-$415.42
Apr 27, 2016
16.21K
Sale
Apr 25 - Apr 27
Form 4
-0.53%
-5.09K
$5.07
-$25.85K
Apr 27, 2016
950.40K
Sale
Apr 25 - Apr 27
Form 4
-4.17%
-708.00
$5.35
-$3.79K
Apr 21, 2016
16.29K
Sale
Apr 19 - Apr 20
Form 4
-4.16%
-41.48K
$5.35
-$222.01K
Apr 21, 2016
955.50K
Sale
Apr 19 - Apr 20
Form 4
-0.44%
-75.00
$5.22
-$391.50
Apr 13, 2016
17.00K
Sale
Apr 11
Form 4
-0.43%
-4.35K
$5.22
-$22.70K
Apr 13, 2016
996.98K
Sale
Apr 11
Form 4
-4.87%
-874.00
$5.28
-$4.61K
Apr 08, 2016
17.07K
Sale
Apr 06 - Apr 08
Form 4
-4.85%
-51.00K
$5.28
-$269.24K
Apr 08, 2016
1.00M
Sale
Apr 06 - Apr 08
Form 4
-1.11%
-202.00
$7.02
-$1.42K
Aug 20, 2015
17.95K
Sale
Aug 18
Form 4
-1.11%
-11.84K
$7.02
-$83.09K
Aug 20, 2015
1.05M
Sale
Aug 18
Form 4
-4.50%
-50.16K
$7.29
-$365.67K
Apr 16, 2015
1.06M
Sale
Apr 14 - Apr 16
Form 4
-4.51%
-857.00
$7.29
-$6.25K
Apr 16, 2015
18.15K
Sale
Apr 14 - Apr 16
Form 4
Sep 30, 2013
1.14M
Options
Sep 30
Form 3
Sep 24, 2013
5.25K
Showing 16 results

Ocera Therapeutics, Inc.

Investor
Updated Dec 13, 2017
Form 4
-100.00%
-47.96K
Dec 13, 2017
Disposition
Dec 11
Form 4
-100.00%
-7.33K
Dec 13, 2017
Disposition
Dec 11
Form 4
-100.00%
-988.28K
Dec 13, 2017
Disposition
Dec 11
Form 3/A
Jul 25, 2013
47.96K
Form 4/A
995.62K
$6.03
$6.00M
Jul 25, 2013
1.04M
Purchase
Jul 15
Form 4
84.80%
1.33M
$6.03
$8.00M
Jul 16, 2013
2.96M
Purchase
Jul 15
Form 3
Jul 16, 2013
1.63M
Showing 7 results

VERACYTE, INC.

Investor
Updated Sep 12, 2014
Form 4
-9.79%
-300.00K
Sep 12, 2014
2.76M
Disposition
Sep 10
Form 4
Nov 04, 2013
3.09M
Options
Nov 04
Form 3
Oct 29, 2013
Showing 3 results

Volcano Corp

Investor
Updated Jun 09, 2008
Form 4
8.86%
4.89K
Jun 09, 2008
60.13K
Acquisition
Apr 24
Form 4
-100.00%
-4.30K
$12.41
-$53.33K
Mar 26, 2008
Sale
Mar 24
Form 4
2,866.60%
53.38K
Sep 12, 2007
55.24K
Acquisition
Sep 12
Form 3/A
Aug 10, 2007
6.16K
Form 3
Jun 14, 2007
1.86K
Showing 5 results

Orexigen Therapeutics, Inc.

Investor
Updated Dec 22, 2011
Form 4
36.81%
938.29K
$7.97
$7.48M
Dec 22, 2011
3.49M
Purchase
Dec 22
Form 4
5.73%
138.10K
$7.54
$1.04M
Dec 21, 2009
2.55M
Purchase
Dec 17 - Dec 18
Form 4
2.12%
50.00K
$6.75
$337.50K
Nov 25, 2009
2.41M
Purchase
Nov 24
Form 4
20.40%
400.00K
$6.93
$2.77M
Nov 24, 2009
2.36M
Purchase
Nov 20 - Nov 23
Form 4
3.27%
62.00K
$6.90
$427.80K
Nov 16, 2009
1.96M
Purchase
Nov 12
Form 4
7.84%
138.00K
$6.93
$956.34K
Nov 12, 2009
1.90M
Purchase
Nov 10 - Nov 11
Form 4
0.79%
13.78K
$7.73
$106.55K
Aug 19, 2009
1.76M
Purchase
Aug 18
Form 4
5.39%
89.43K
$7.75
$692.66K
Aug 18, 2009
1.75M
Purchase
Aug 14 - Aug 17
Form 4
33.18%
413.00K
$8.00
$3.30M
Aug 14, 2009
1.66M
Purchase
Aug 12 - Aug 13
Form 4
9.15%
104.30K
$7.60
$792.68K
Aug 13, 2009
1.24M
Purchase
Aug 11
Form 4
132.57%
650.00K
$7.50
$4.88M
Jul 24, 2009
1.14M
Purchase
Jul 23
Form 4
490.30K
$4.70
$2.30M
Dec 10, 2008
490.30K
Purchase
Dec 08 - Dec 09
Form 3/A
Aug 20, 2008
6.49K
Form 3
Nov 29, 2007
1.96K
Showing 14 results

ZOGENIX, INC.

Investor
Updated Sep 20, 2011
Form 4
53.09%
3.50M
$2.00
$7.00M
Sep 20, 2011
10.09M
Purchase
Sep 16
Form 4
55.39%
2.35M
$4.00
Dec 01, 2010
6.59M
Purchase
Nov 29
Form 3
Nov 22, 2010
11.00K
Showing 3 results

TANDEM DIABETES CARE INC

Investor
Updated Nov 19, 2013
Form 4
-6.30%
-242.11K
Nov 19, 2013
3.60M
Options
Nov 19
Form 4
-6.30%
-242.11K
Nov 19, 2013
3.60M
Options
Nov 19
Form 3
Nov 13, 2013
Showing 3 results

Vanda Pharmaceuticals Inc.

Investor
Updated Mar 30, 2010
Form 4
7.28K
Mar 30, 2010
7.28K
Acq/Dis
Mar 26
Form 4
15.00K
Aug 28, 2009
15.00K
Grant
Aug 27
Form 4
15.00K
May 12, 2008
15.00K
Grant
May 08
Form 4
15.00K
May 18, 2007
15.00K
Grant
May 16
Form 3
Apr 12, 2006
Showing 5 results

ALIMERA SCIENCES INC

Investor
Updated Jan 06, 2023
Form 4
6.00K
Jan 06, 2023
6.00K
Grant
Jan 04
Form 4
6.00K
Nov 04, 2021
6.00K
Grant
Nov 02
Form 4
191.96%
215.00
Sep 17, 2021
327.00
Acquisition
Sep 17
Form 4
3.33K
Jun 22, 2020
3.33K
Grant
Jun 18
Form 4
50.00K
Jun 21, 2019
50.00K
Grant
Jun 19
Form 4
40.00K
Jun 21, 2018
40.00K
Grant
Jun 19
Form 4
40.00K
Jun 26, 2017
40.00K
Grant
Jun 22
Form 4
20.00K
Jun 27, 2016
20.00K
Grant
Jun 23
Form 4
1.69K
Jul 17, 2015
1.69K
Acq/Dis
Jul 16
Form 4
20.00K
Jun 25, 2015
20.00K
Grant
Jun 25
Form 4
20.00K
Jun 10, 2014
20.00K
Grant
Jun 09
Form 4
20.00K
Jun 19, 2013
20.00K
Grant
Jun 18
Form 4
12.50K
Feb 01, 2013
12.50K
Grant
Jan 30
Form 4
7.50K
Jun 15, 2012
7.50K
Grant
Jun 14
Form 4
7.50K
Jun 09, 2011
7.50K
Grant
Jun 08
Form 4
7.50K
Apr 27, 2010
7.50K
Grant
Apr 27
Form 3
Apr 21, 2010
Showing 17 results

NOVACEA INC

Investor
Updated May 09, 2006
Form 3
May 09, 2006
100.36K
Showing 1 results

Achaogen Inc

Investor
Updated Mar 11, 2014
Form 3
Mar 11, 2014
Showing 1 results

ACHILLION PHARMACEUTICALS INC

Investor
Updated Jan 18, 2013
Form 4
-13.60%
-933.54K
Jan 18, 2013
6.02M
Disposition
Jan 18
Form 4
-13.88%
-1.11M
Jun 04, 2012
6.95M
Disposition
May 31
Form 4
25.00K
Oct 08, 2010
25.00K
Acq/Dis
Oct 06
Form 3
Aug 23, 2010
8.03M
Showing 4 results

Celator Pharmaceuticals Inc

Investor
Updated Jan 15, 2013
Form 3
Jan 15, 2013
5.87K
Showing 1 results

CADENCE PHARMACEUTICALS INC

Investor
Updated Oct 24, 2006
Form 3
Oct 24, 2006
27.50K
Showing 1 results

Northstar Neuroscience, Inc.

Investor
Updated May 04, 2006
Form 3
May 04, 2006
3.33K
Showing 1 results